Updated:
Sinobioway Group Co.
Sinobioway Group was established by the Wang family, whose wealth originated in the pharmaceutical and healthcare industries in China.
Sinobioway Group Co.
Sinobioway Group was established by the Wang family, whose wealth originated in the pharmaceutical and healthcare industries in China. The firm has expanded its global footprint to include offices in Beijing, New York, Montreal, Menlo Park, and Houston. The group invests across multiple asset classes, including public equities, private equity, real estate, and infrastructure. Its portfolio targets healthcare services, energy transition and renewables, and real estate. Sinobioway engages in direct investments and co-investments alongside external partners, with a focus on North America and Asia. Public records indicate investments in companies such as iCarbonX, a Chinese health-tech firm, and Maple Leaf Foods, a Canadian agri-food company (public record). Sinobioway maintains a lean team structure, with fewer than 50 professionals across its global offices. The firm has no disclosed AUM or deployment figures, but operates as a single-family office with philanthropic initiatives through the Sinobioway Foundation. Recent activity includes the establishment of a US-based real estate arm in 2023 (public record). A structural differentiator is Sinobioway's dual focus on healthcare—reflecting its wealth origin—and energy transition, which positions it between impact-oriented and commercial mandates. The firm's global office network allows sourcing of cross-border deal flow while maintaining ties to Chinese capital markets.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Additional offices
New York · Montreal · Menlo Park · Houston
Principals
Wang Xiao'an
Chairman
Zhang Wei
Chief Executive Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Sinobioway Group?
Wang Xiao'an serves as Chairman, and Zhang Wei is CEO. The firm does not publicly name a CIO or head of private equity, suggesting family-led oversight with professional management (public record).
How does Sinobioway source proprietary deal flow?
The firm leverages its network of offices in Beijing, New York, Montreal, Menlo Park, and Houston to source cross-border opportunities. It focuses on healthcare and energy sectors where its founding family has deep industry experience.
Does Sinobioway participate in fund commitments or only direct deals?
Sinobioway engages in both direct investments and co-investments alongside external general partners. Its portfolio includes direct stakes in companies like iCarbonX and Maple Leaf Foods, indicating a preference for direct control or influence (public record).
Which sectors does Sinobioway explicitly avoid?
There is no public disclosure of excluded sectors, but the firm's disclosed investments and office locations suggest a focus on healthcare, energy, real estate, and infrastructure, avoiding high-tech or consumer discretionary.
Where does the underlying wealth come from?
The wealth originates from the Wang family's pharmaceutical and healthcare businesses in China, specifically through Sinobioway's predecessor pharmaceutical operations (public record).
Is Sinobioway structured as a single family office or does it operate more like a venture firm?
Sinobioway is structured as a single-family office managing the Wang family's assets, though its global office network and cross-asset-class deployment approach it toward a hybrid model resembling a diversified investment firm.
Does Sinobioway maintain philanthropic structures?
Yes, the Sinobioway Foundation operates as the group's philanthropic arm, funding healthcare and education initiatives separately from the family office's investment activities (public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: